These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 17606885)
1. Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene. Gourfinkel-An I; Duyckaerts C; Camuzat A; Meyrignac C; Sonderegger P; Baulac M; Brice A Neurology; 2007 Jul; 69(1):79-83. PubMed ID: 17606885 [TBL] [Abstract][Full Text] [Related]
2. Familial dementia caused by polymerization of mutant neuroserpin. Davis RL; Shrimpton AE; Holohan PD; Bradshaw C; Feiglin D; Collins GH; Sonderegger P; Kinter J; Becker LM; Lacbawan F; Krasnewich D; Muenke M; Lawrence DA; Yerby MS; Shaw CM; Gooptu B; Elliott PR; Finch JT; Carrell RW; Lomas DA Nature; 1999 Sep; 401(6751):376-9. PubMed ID: 10517635 [TBL] [Abstract][Full Text] [Related]
3. Mutations in the neuroserpin gene are rare in familial dementia. French Alzheimer's Disease and Fronto-Temporal Dementia Genetics Study Groups. Ann Neurol; 2000 May; 47(5):688. PubMed ID: 10805351 [No Abstract] [Full Text] [Related]
4. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy. Takao M; Benson MD; Murrell JR; Yazaki M; Piccardo P; Unverzagt FW; Davis RL; Holohan PD; Lawrence DA; Richardson R; Farlow MR; Ghetti B J Neuropathol Exp Neurol; 2000 Dec; 59(12):1070-86. PubMed ID: 11138927 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies. Galliciotti G; Glatzel M; Kinter J; Kozlov SV; Cinelli P; Rülicke T; Sonderegger P Am J Pathol; 2007 Apr; 170(4):1305-13. PubMed ID: 17392169 [TBL] [Abstract][Full Text] [Related]
6. Association between conformational mutations in neuroserpin and onset and severity of dementia. Davis RL; Shrimpton AE; Carrell RW; Lomas DA; Gerhard L; Baumann B; Lawrence DA; Yepes M; Kim TS; Ghetti B; Piccardo P; Takao M; Lacbawan F; Muenke M; Sifers RN; Bradshaw CB; Kent PF; Collins GH; Larocca D; Holohan PD Lancet; 2002 Jun; 359(9325):2242-7. PubMed ID: 12103288 [TBL] [Abstract][Full Text] [Related]
7. Cognitive deficits associated with a recently reported familial neurodegenerative disease: familial encephalopathy with neuroserpin inclusion bodies. Bradshaw CB; Davis RL; Shrimpton AE; Holohan PD; Rea CB; Fieglin D; Kent P; Collins GH Arch Neurol; 2001 Sep; 58(9):1429-34. PubMed ID: 11559315 [TBL] [Abstract][Full Text] [Related]
8. Familial conformational diseases and dementias. Crowther DC Hum Mutat; 2002 Jul; 20(1):1-14. PubMed ID: 12112652 [TBL] [Abstract][Full Text] [Related]
9. SERPINI1 pathogenic variants: An emerging cause of childhood-onset progressive myoclonic epilepsy. Ranza E; Garcia-Tarodo S; Varvagiannis K; Guipponi M; Lobrinus JA; Bottani A; Kern I; Kurian M; Pittet MP; Antonarakis SE; Fluss J; Korff CM Am J Med Genet A; 2017 Sep; 173(9):2456-2460. PubMed ID: 28631894 [TBL] [Abstract][Full Text] [Related]
10. Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. Belorgey D; Sharp LK; Crowther DC; Onda M; Johansson J; Lomas DA Eur J Biochem; 2004 Aug; 271(16):3360-7. PubMed ID: 15291813 [TBL] [Abstract][Full Text] [Related]
11. Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene. Hagen MC; Murrell JR; Delisle MB; Andermann E; Andermann F; Guiot MC; Ghetti B Brain Pathol; 2011 Sep; 21(5):575-82. PubMed ID: 21435071 [TBL] [Abstract][Full Text] [Related]
12. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Yepes M; Lawrence DA Thromb Haemost; 2004 Mar; 91(3):457-64. PubMed ID: 14983220 [TBL] [Abstract][Full Text] [Related]